FDA Inspection 965285 — Medtronic Heart Valves Division

Medtronic Heart Valves Division — FEI 2025587

The FDA completed an inspection of Medtronic Heart Valves Division on Mar 30, 2016 in Santa Ana, CA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 2 citations were issued during this inspection. Product area: Devices.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Mar 30, 2016
Fiscal Year
2016
Product Type
Devices
Project Area
Project Evaluation: Devices
Location
Santa Ana, CA (United States)

Additional details

Postmarket Audit Inspections

Citations

IDCFRDescription
317221 CFR 820.198(c)Investigation of device failures
368021 CFR 820.70(a)Process control procedures, Lack of or inadequate procedures

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.